However, clinical studies have shown that blockade of TNF signaling alone is insufficient for improving insulin resistance or endothelial function in obese humans, suggesting that other pathways are involved in obesity-associated metabolic dysregulation (76). Here, TNF is linked to obesity due to melanocortin 4 receptor deficiency.